Evidence map›Paper›PMID 31336956›Full record

ArticleInternational journal of molecular sciences2019

Paola Concolino, Gianfranco Gelli, Roberta Rizza, Alessandra Costella, Giovanni Scambia, Ettore Capoluongo

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Case Report: Clinical impact ofFrontiers in oncology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Spectrum of GermlineCancers · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Paola ConcolinoDipartimento Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, 00168 Rome, Italy. paola.concolino@policlinicogemelli.it.ORCID 0000-0002-0523-5744
Gianfranco GelliAmbulatorio Genetica Medica e Citogenetica Clinica, Poliambulatorio Sant'Anna, ASL Roma 1, Via Garigliano 55, 00198 Rome, Italy.
Roberta RizzaDipartimento Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, 00168 Rome, Italy.
Alessandra CostellaDipartimento Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, 00168 Rome, Italy.
Giovanni ScambiaDipartimento Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, 00168 Rome, Italy.
Ettore CapoluongoDipartimento Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, 00168 Rome, Italy.
Agostino Gemelli University Polyclinic · ITASL Roma · ITUniversità Cattolica del Sacro Cuore · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this report is to describe results of

Indexed as

Genes, BRCA1Genes, BRCA2Genetic Association StudiesGenetic Predisposition to DiseaseHigh-Throughput Nucleotide SequencingAdultAgedAllelesAmino Acid SubstitutionBiomarkers, TumorBreast NeoplasmsCohort StudiesComputational BiologyDNA Copy Number VariationsDNA Mutational AnalysisFemaleBiomarkers, TumorBRCA1/2 genesbreast cancergenetic testingmolecular diagnosisNGSovarian cancer

Identifiers

PMID31336956
PMCPMC6678297
OpenAlexW2960406634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.